BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on ...
View Sinovac Biotech Ltd. SVA stock quote prices, financial information, real-time forecasts, and company news from CNN.
Corrects the Company’s Misrepresentations of Vivo’s Capital Contributions, Which Have Been Critical to Sinovac’s Commercial Success and Ability to Return Capital to Shareholders Calls on All ...
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline ...
Sinovac Biotech (SVA) kicked off the enrollment for a Phase III clinical trial on a vaccine candidate to prevent HFMD caused by both Enterovirus 71 and Coxsackievirus 16. Notably, no multivalent ...
Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 ...
Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter Sinovac Biotech ( (SVA)) has shared an announcement. Sinovac Biotech Ltd., a ...
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal ...
We recently compiled a list of the 10 Largest Biotech Hedge Funds and Their Top Stock Picks. In this article, we are going to take a look at where Sinovac Biotech Ltd. (NASDAQ:SVA) stands against the ...
Given the surge of Omicron cases in Asia, the new research lends urgency to vaccination campaigns in China and Hong Kong. By Benjamin Mueller Beijing once said it had two mRNA shots within reach and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results